NEWS

Donald Cant Watts Corke is a Supporting Partner of the AIPM WA Chapter 2021 Project Management Achie...

Donald Cant Watts Corke is a Supporting Partner of the Australian Institute of Project Management (AIPM) 2021 Project Management Achievement Awards, WA Chapter event on the evening.....

Read More →
paper-plane.svg

Subscribe to Our Newsletter

Get the latest trends and brand updates delivered straight to your inbox.

Pancreatic Cancer Awareness Day 2021 at Donald Cant Watts Corke with Walter and Eliza Hall Institute (WEHI)

Latest News

Written by

Managing Director, Infrastructure

On Pancreatic Cancer Awareness Day 2021, DCWC were joined virtually by Dr. Tracy Putockzi, Laboratory Head, Personalised Oncology division at Walter and Eliza Hall Institute of Medical Research (WEHI), to share her team’s research, using cutting-edge organoids technology, to uncover new and effective precision treatments for pancreatic cancer.

DCWC is proud of our continued commitment to helping fund breakthrough research, supporting the crucial work undertaken by WEHI – Australia’s oldest and longest-serving medical research institute. The historic association between DCWC and WEHI is one that involved our specialist services for the institute’s initial development in 1981 and several subsequent projects since.

World Pancreatic Cancer Day brings people around the world together to highlight the need for greater awareness, funding and research for pancreatic cancer. Sadly, survival rates for pancreatic cancer are amongst the lowest of all cancers. Research is the only hope of improved quality of life and improved survival for people living with pancreatic cancer.

Towards a better future of people living with pancreatic cancer

WEHI’s Dr Tracy Putoczki and her team are leveraging cutting-edge organoids based technology to better understand pancreatic cancer biology. This is helping to uncover new ways to combat this disease.

Organoids are miniature replicas of cancer patients’ tumours that are grown in the laboratory. Because organoids mimic a patient’s own cancer, they can be used to:

  • accelerate our understanding of how pancreatic cancer grows and spreads and what its vulnerabilities are
  • allow us to test which drugs – both new and existing – may be able to kill a patient’s cancer
  • enables patients to be categorised to receive the most effective treatment for their own specific tumour – enabling a more personalised approach to therapy for each individual pancreatic cancer patient
  • uncover better ways to diagnose patients
  • identify better ways to prevent resistance to treatments; and
  • discover new and effective precision treatments.

Most importantly, this research gives hope of improved quality of life and improved survival for people living with pancreatic cancer.

The historic association between DCWC and WEHI is one that has been incredibly productive. In 2020, DCWC renewed its pledge to commit $100,000 to WEHI over the next three years, supporting WEHI’s pancreatic cancer research.

READ MORE ABOUT DCWC'S COMMITMENT →

wehi-logo-2020

Read more about WEHI and their important research. 

May We Also Recommend

NEWS & MEDIA

Donald Cant Watts Corke is a Supporting Partner of...

Donald Cant Watts Corke is a Supporting Partner of the Australian Institute... Read More →

NEWS & MEDIA

Donald Cant Watts Corke, Henry Ashton nomination i...

Henry Ashton, Associate Project Manager in our Melbourne office has been no... Read More →

NEWS & MEDIA

Pancreatic Cancer Awareness Day 2021 at Donald Can...

On Pancreatic Cancer Awareness Day 2021, DCWC were joined virtually by Dr. ... Read More →

GUIDE

Implications of the Retirement Villages Amendment Act 2022

The retirement living sector in New South Wales has new legislation around the requirement of asset management plans, that came into ef...

Download a Copy

WHITEPAPER

Navigating Successful PPP In Infrastructure

Public-Private Partnerships are nothing new, yet there is an increasing need for partnerships that offer an increased opportunity to de...

Read Now